Skip to main content
. 2023 Sep 21;14:1235514. doi: 10.3389/fimmu.2023.1235514

Table 1.

Clinical Parameters.

Healthy Controls
(n=25)
RA Patients
(n= 67)
Age, years 30.9 ± 2.5 47.4 ± 11.1
Female/male, no.s 21/4 62/5
Disease duration, years N.A 7.5 ± 3.5
Rheumatoid factor-positive, n (%) N.D 71.6
Anti-CCP positive, n (%) N.D 55.2
CRP, mg/dl N.D 49.7 ± 44.1
ESR, mm/hour N.D 62.9 ± 33.2
DAS28 N.A 5.20 ± 0.9
Previous medications, n (%)
Corticosteroids N.A 38(67)
DMARDS N.A
  Methotrexate 62(67)
  HCQS 49(67)
  Leflunomide 24(67)
NSAIDS N.A 6(67)